SNDL

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

benzingaai2023_modern_computer_screen_with_stock_chart_stock__c8dae12f-563b-4c3d-ba96-79a17f4c62e4_0

News

Movers

TLRY

Tilray Brands stock is trading lower on Monday, alongside other cannabis-related stocks, following President Donald Trump&#39;s announcement of new tariffs on imported goods from Canada, Mexico and China, set to take effect Tuesday.

What&#39;s Going On With Tilray Brands Stock Monday?

Ben Caplan-Flipping-through-manuscript-2-scaled-1-e1673414167225 copy

Cannabis

Government

Regulations

Health Care

Exclusives

Interview

CRLBF

GTBIF

MSOS

TCNNF

Surgeon general warns about alcohol&#39;s cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.

EXCLUSIVE: Cannabis Physician Says Surgeon General&#39;s Alcohol Cancer Risk Warning Is &#39;Wake-Up Call&#39;

AI-Generated Image

Politics

Markets

ETFs

CNTMF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

ITHUF

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.

Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump&#39;s Attorney General Nominee

SNDL Inc

Press Releases

SNDL Announces Departure of Liquor Segment President

SNDL Successfully Completes Privatization of Nova and Welcomes New Director

SNDL to Announce Third Quarter 2024 Financial Results on November 5, 2024

SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition

Earnings

SNDL Reports Third Quarter 2024 Financial and Operational Results

SNDL Announces Renewal of Share Repurchase Program

SNDL Appoints New Chief Information Officer and New President, Liquor Division

Contracts

HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL

HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets

SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025

CSE:HYTN

HYTNF

TSX:NOVC

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharma

BGM Group

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Evolus

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

GH Research

Harrow

Maze Therapeutics

MBX Biosciences

Nuvation Bio

Omeros

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

SIGA Technologies

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Tilray Brands

Trevi Therapeutics

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings

Zevra Therapeutics

Canaccord Genuity

Cantor Fitzgerald

BMO Capital

Sundial Growers

Comments

SNDL

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga